United Therapeutics Corp (NASDAQ:UTHR)
A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
shaileshnita
(77.83)
Submitted: 4/22/2013 2:09:44 PM :
Start Price:
$61.11
UTHR Score:
+6.15
It looks cheap.
Recs
OklaBoston
(< 20)
Submitted: 12/23/2012 10:55:34 AM :
Start Price:
$52.19
UTHR Score:
+18.89
CEO open market buying, primarily.
Separate blocks, 3000 shares each, last week.
Recs
picbois
(97.75)
Submitted: 6/24/2012 6:01:01 PM :
Start Price:
$47.71
UTHR Score:
+18.56
The figures are amazing, many product protected by patent in disease that are not well served for medication.
Recs
Orthonormal
(92.73)
Submitted: 3/21/2012 1:27:17 PM :
Start Price:
$48.33
UTHR Score:
+24.21
Magic Formula pick
Recs
Recs
MarkP28665
(33.89)
Submitted: 12/21/2011 8:32:37 PM :
Start Price:
$45.04
UTHR Score:
+19.63
Promising pipeline
Recs
Calinvestments
(97.48)
Submitted: 5/13/2011 1:29:33 PM :
Start Price:
$66.81
UTHR Score:
-21.12
This is a small/mid cap high growth stock that should outperform the S&P during the bull market.
Recs
GTROwner
(66.26)
Submitted: 4/27/2011 11:32:51 PM :
Start Price:
$70.38
UTHR Score:
-24.99
Will become the dominant player in the PAH market, strong pipeline in multiple high-profit potential orphan diseases like PAH, ILD, PF, Cancer, Stem Cell, and Virology. 30% annual growth over the last 5+ years.
Recs
HardnoseDotCom
(74.77)
Submitted: 4/25/2011 1:31:30 PM :
Start Price:
$69.52
UTHR Score:
-25.45
low PEG, strong price uptrend
Recs
Recs
LexTNZorro
(78.52)
Submitted: 5/4/2009 3:21:31 AM :
Start Price:
$33.72
UTHR Score:
+14.60
http://seekingalpha.com/article/133869-fda-clinical-trial-updates-watson-pharma-united-therapeutics-auxilium-dendreon?source=feed
Recs
fanomatic
(< 20)
Submitted: 4/20/2009 2:44:19 PM :
Start Price:
$28.44
UTHR Score:
-41.76
This company is limited with products..... and competition for any existing product(s) will happen soon. Its medical device company (Medicomp) is really a small marginally profitable-if at all -firm run by a youngster who was given the job AND isn't a real board certified/practicing MD.
UTHR stock owners should better prepare to SELL now before and when the stock gets to the mid 40's.
Recs
wassercom
(87.56)
Submitted: 2/22/2009 9:15:12 AM :
Start Price:
$34.59
UTHR Score:
-17.10
Pipeline looks good.
Recs
nysegal
(36.09)
Submitted: 8/5/2008 2:24:22 AM :
Start Price:
$55.78
UTHR Score:
-12.67
UTHR is a terrific growth stock; accellerating earnings -- 80% in 08 and 68% in 09; recently reported fantastic earnings above street estimates.
Recs
ThxUT
(< 20)
Submitted: 3/13/2008 12:29:05 PM :
Start Price:
$39.76
UTHR Score:
+40.69
UT leads the market in pulmonary hypertension with rapid growth and a better product than all the competitors.
Recs
SteelBreez99
(82.55)
Submitted: 12/11/2007 5:47:28 PM :
Start Price:
$54.00
UTHR Score:
+12.31
VALUE LINES - TIMELY STOCKS IN TIMELY INDUSTRIES
Recs
qasamm
(70.00)
Submitted: 12/11/2007 1:45:24 PM :
Start Price:
$53.69
UTHR Score:
+14.16
Amazing leadership- many great suprises found in each annual report (no debt, diversity of pipeline, etc.)
Recs
MFClobberMeSilly
(63.97)
Submitted: 11/9/2007 8:27:36 AM :
Start Price:
$50.01
UTHR Score:
+18.26
Best biomed
Recs
Recs
JasonA25
(< 20)
Submitted: 3/2/2007 12:30:21 PM :
Start Price:
$27.56
UTHR Score:
+124.18
NICE GROWTH EST, POSITIVE CASH, WILL BE A NICE STOCK FOR THE FUTURE EVEN IF THERE IS A BEAR MARKET COMING UP.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 22 : 1 2 Next »